Just how good are antipsychotics at preventing relapse? Bridging the efficacy-effectiveness gap

pills-water

Samei Huda summarises a new network meta-analysis in the Lancet Psychiatry on the efficacy and effectiveness of antipsychotics for schizophrenia in research settings, such as randomised controlled trials, versus real-world and clinical settings.

[read the full story...]

Optimal antipsychotic dosing in first-episode schizophrenia: how much is too little, too much, or just right?

towfiqu-barbhuiya-Yw9Vgr6i_-0-unsplash

Joe Pierre reports on the first published study exploring the relationship between antipsychotic dose and risk of relapse in first episode schizophrenia, which suggests that standard antipsychotic dosing is best for relapse prevention.

[read the full story...]

Preventing suicide is everybody’s business: a global perspective #LancetSuicideSeminar

kenrick-mills-nn6nhhhf84M-unsplash

Ravivarma Rao Panirselvam summarises the recently published Lancet Seminar on Suicide and Self-Harm, and highlights the free webinar due too take place on Monday 4th July 2022.

[read the full story...]